Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Takeda
Center for International Blood and Marrow Transplant Research
University of Washington
Memorial Sloan Kettering Cancer Center
Ohio State University Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Hackensack Meridian Health
Massachusetts General Hospital
Novartis
M.D. Anderson Cancer Center
Mayo Clinic
University of Miami
Fred Hutchinson Cancer Center
Dartmouth-Hitchcock Medical Center
Children's Hospital Medical Center, Cincinnati
Memorial Sloan Kettering Cancer Center
Novartis
Center for International Blood and Marrow Transplant Research
City of Hope Medical Center
Dana-Farber Cancer Institute
MPN Research Foundation
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Stanford University
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Massachusetts General Hospital
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
Incyte Corporation
Fred Hutchinson Cancer Center
Constellation Pharmaceuticals
University of Alabama at Birmingham
University of Alabama at Birmingham
Massachusetts General Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University
City of Hope Medical Center
Children's Oncology Group